Systolic and diastolic blood pressures were measured (Cardiomax II, Instruments, Columbus, OH) from the aorta, via the femoral artery, under pentobarbital anesthesia (50 mg/kg, administered intraperitoneally)
What to Expect: General Timeline Outcomes differ from person to person depending on age, starting hormone levels, and how consistently you follow the protocol
68 TingleM
Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously, producing an average of 24.2% body weight reduction in Phase 2 clinical trials at the 12mg dose
Early data from Phase 1 and initial Phase 2 investigations helped researchers evaluate the safety profile, pharmacokinetic characteristics, and biological activity of cagrilintide, supporting progression into larger clinical development programs